AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimisave M CP 1mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Eris Lifesciences Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimisave M CP 1mg/500mg Tablet

Combiprep DM, a 1mg/500mg tablet, is an antidiabetic medication combining two drugs to manage type 2 diabetes in adults. It effectively regulates blood glucose. This medication should be taken with food, consistently at the same time daily for optimal results. Dosage is determined by your physician and may adjust based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, risking kidney complications, vision impairment, neuropathy, and limb loss. This medicine is only one component of a comprehensive diabetes management plan encompassing a healthy diet, regular exercise, and weight management as directed by your doctor. Lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn its symptoms (sweating, dizziness, headache, tremors) and treatment. Maintain regular meals and carry a fast-acting glucose source. Alcohol increases hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver disease. Inform your doctor of any heart conditions before starting treatment, as it may be unsuitable. Pregnant or breastfeeding individuals should seek medical advice before use. Regular blood glucose monitoring is essential, along with potential blood tests to track blood cell counts and liver function.

Uses of Glimisave M CP 1mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Glimisave M CP 1mg/500mg Tablet:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Glimisave M CP 1mg/500mg tablets with food.

Common Side effects of Glimisave M CP 1mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimisave M CP 1mg/500mg Tablet:

Administer this medication precisely as prescribed by your physician, both in terms of dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Glimisave M CP 1mg/500mg Tablet with a meal.

How Glimisave M CP 1mg/500mg Tablet works:

Glimisave M CP, a 1mg/500mg tablet, combines the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Glimisave M CP 1mg/500mg tablets poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glimisave M CP 1mg/500mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice before use.

Breast feedingBreast feedingUNSAFE

Breastfeeding mothers should not take Glimisave M CP 1mg/500mg Tablets. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving may be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Caution is advised when prescribing Glimisave M CP 1mg/500mg tablets to individuals with impaired renal function; dosage modification may be necessary. A physician's consultation is recommended. For patients exhibiting severe kidney disease, the use of Glimisave M CP 1mg/500mg tablets is contraindicated. Regular assessment of kidney function is prudent during treatment.

LiverLiverCAUTION

The use of Glimisave M CP 1mg/500mg tablets requires careful consideration in individuals with liver impairment. Dosage modification may be necessary. Medical advice is recommended. For patients experiencing mild to moderate liver disease, a low initial dose is typically prescribed; however, its administration is contraindicated in those with severe hepatic dysfunction.

What if you forget to take Glimisave M CP 1mg/500mg Tablet :

Should you forget a dose of Glimisave M CP 1mg/500mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimisave M CP 1mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Treatment

FAQs on Glimisave M CP 1mg/500mg Tablet

Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimisave M CP 1mg/500mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in individuals with kidney disease, older adults, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue use and seek immediate medical attention.
Glimisave M CP 1mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This combination improves blood sugar control when used with a healthy diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for treating type 1 DM.
Glimisave M CP 1mg/500mg tablets may cause common side effects such as low blood sugar, taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged Glimisave M CP 1mg/500mg Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glimisave M CP 1mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with skipped meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glimisave M CP 1mg/500mg tablets and alcohol is unsafe. This combination can lower blood sugar, causing hypoglycemia, and increase the risk of lactic acidosis.
Glimisave M CP 1mg/500mg ...
105
MRP 121
13% off